127 related articles for article (PubMed ID: 34763941)
21. Centralized primary care of advanced ovarian cancer improves complete cytoreduction and survival - A population-based cohort study.
Dahm-Kähler P; Palmqvist C; Staf C; Holmberg E; Johannesson L
Gynecol Oncol; 2016 Aug; 142(2):211-6. PubMed ID: 27238084
[TBL] [Abstract][Full Text] [Related]
22. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
23. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
24. Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.
Matsuo K; Machida H; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Mikami M
Obstet Gynecol; 2019 Nov; 134(5):1017-1026. PubMed ID: 31599824
[TBL] [Abstract][Full Text] [Related]
25. No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials.
Abdel-Rahman ME; Butler J; Sydes MR; Parmar MK; Gordon E; Harper P; Williams C; Crook A; Sandercock J; Swart AM; Rachet B; Coleman MP;
Br J Cancer; 2014 Jul; 111(3):589-97. PubMed ID: 24918817
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer.
Rauh-Hain JA; Foley OW; Winograd D; Andrade C; Clark RM; Vargas RJ; Hinchcliff EM; Esselen KM; Horowitz NS; del Carmen MG
Am J Obstet Gynecol; 2015 May; 212(5):600.e1-8. PubMed ID: 25514761
[TBL] [Abstract][Full Text] [Related]
27. Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study.
Duus AH; Hannibal CG; Baandrup L; Zheng G; Galanakis M; Maltesen T; Hertzum-Larsen R; Mørch LS; Kjær SK
Int J Cancer; 2024 Jul; 155(1):19-26. PubMed ID: 38532545
[TBL] [Abstract][Full Text] [Related]
28. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
[TBL] [Abstract][Full Text] [Related]
29. Socioeconomic status and epithelial ovarian cancer survival in Sweden.
Weiderpass E; Oh JK; Algeri S; Bellocco R
Cancer Causes Control; 2014 Aug; 25(8):1063-73. PubMed ID: 24906473
[TBL] [Abstract][Full Text] [Related]
30. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
31. Statin use and mortality among ovarian cancer patients: A population-based cohort study.
Verdoodt F; Kjaer Hansen M; Kjaer SK; Pottegård A; Friis S; Dehlendorff C
Int J Cancer; 2017 Jul; 141(2):279-286. PubMed ID: 28411390
[TBL] [Abstract][Full Text] [Related]
32. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.
Kolomeyevskaya NV; Szender JB; Zirpoli G; Minlikeeva A; Friel G; Cannioto RA; Brightwell RM; Grzankowski KS; Moysich KB
Int J Gynecol Cancer; 2015 Nov; 25(9):1587-92. PubMed ID: 26273932
[TBL] [Abstract][Full Text] [Related]
33. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals.
Paulsen T; Kjaerheim K; Kaern J; Tretli S; Tropé C
Int J Gynecol Cancer; 2006; 16 Suppl 1():11-7. PubMed ID: 16515561
[TBL] [Abstract][Full Text] [Related]
34. Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries.
Trabert B; Coburn SB; Mariani A; Yang HP; Rosenberg PS; Gierach GL; Wentzensen N; Cronin KA; Sherman ME
J Natl Cancer Inst; 2018 Jul; 110(7):750-757. PubMed ID: 29281053
[TBL] [Abstract][Full Text] [Related]
35. Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected data.
Irodi A; Rye T; Herbert K; Churchman M; Bartos C; Mackean M; Nussey F; Herrington CS; Gourley C; Hollis RL
BJOG; 2020 Oct; 127(11):1409-1420. PubMed ID: 32285600
[TBL] [Abstract][Full Text] [Related]
36. Survival of ovarian cancer patients in Denmark: Results from the Danish gynaecological cancer group (DGCG) database, 1995-2012.
Edwards HM; Noer MC; Sperling CD; Nguyen-Nielsen M; Lundvall L; Christensen IJ; Høgdall C
Acta Oncol; 2016 Jun; 55 Suppl 2():36-43. PubMed ID: 27355258
[TBL] [Abstract][Full Text] [Related]
37. Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake?
Höhn AK; Klagges S; Gläser A; Taubenheim S; Dornhöfer N; Einenkel J; Hiller GGR; Brambs CE; Horn LC
J Cancer Res Clin Oncol; 2021 Mar; 147(3):911-925. PubMed ID: 32915262
[TBL] [Abstract][Full Text] [Related]
38. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study.
Anuradha S; Webb PM; Blomfield P; Brand AH; Friedlander M; Leung Y; Obermair A; Oehler MK; Quinn M; Steer C; Jordan SJ
Med J Aust; 2014 Sep; 201(5):283-8. PubMed ID: 25163381
[TBL] [Abstract][Full Text] [Related]
39. Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study.
Cabasag CJ; Butler J; Arnold M; Rutherford M; Bardot A; Ferlay J; Morgan E; Møller B; Gavin A; Norell CH; Harrison S; Saint-Jacques N; Eden M; Rous B; Nordin A; Hanna L; Kwon J; Cohen PA; Altman AD; Shack L; Kozie S; Engholm G; De P; Sykes P; Porter G; Ferguson S; Walsh P; Trevithick R; Tervonen H; O'Connell D; Bray F; Soerjomataram I
Gynecol Oncol; 2020 Apr; 157(1):234-244. PubMed ID: 32005583
[TBL] [Abstract][Full Text] [Related]
40. Non-epithelial ovarian cancer in Denmark - Incidence and survival over nearly 40 years.
Bennetsen AKK; Baandrup L; Aalborg GL; Kjaer SK
Gynecol Oncol; 2020 Jun; 157(3):693-699. PubMed ID: 32223987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
